D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 96 Citations 44,169 450 World Ranking 4485 National Ranking 146

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Alzheimer's disease
  • Disease

Alzheimer's disease, Dementia, Pathology, Pittsburgh compound B and Internal medicine are his primary areas of study. Alzheimer's disease is a subfield of Disease that Christopher C. Rowe studies. His Disease study incorporates themes from Biomarker, Cognition, Neuroimaging and Case-control study.

His research in Dementia intersects with topics in Cerebellar cortex, Episodic memory, Gerontology and Clinical psychology. In his research, Neocortex and Precuneus is intimately related to Posterior cingulate, which falls under the overarching field of Pathology. He has included themes like Diabetes mellitus and Oncology in his Internal medicine study.

His most cited work include:

  • Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (4114 citations)
  • NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease (2145 citations)
  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (1750 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Disease, Internal medicine, Alzheimer's disease, Pathology and Dementia. Christopher C. Rowe is interested in Cognitive impairment, which is a field of Disease. His Internal medicine research incorporates themes from Endocrinology, Oncology and Cardiology.

In Alzheimer's disease, Christopher C. Rowe works on issues like Neuroscience, which are connected to Neurodegeneration. Christopher C. Rowe combines subjects such as Psychiatry, Neuroimaging, Prospective cohort study and Neuropsychology with his study of Dementia. Christopher C. Rowe has researched Cognitive decline in several fields, including Cognition and Gerontology.

He most often published in these fields:

  • Disease (30.11%)
  • Internal medicine (28.66%)
  • Alzheimer's disease (23.34%)

What were the highlights of his more recent work (between 2017-2021)?

  • Disease (30.11%)
  • Internal medicine (28.66%)
  • Dementia (22.61%)

In recent papers he was focusing on the following fields of study:

Christopher C. Rowe spends much of his time researching Disease, Internal medicine, Dementia, Alzheimer's disease and Cognitive decline. His Disease research is classified as research in Pathology. He focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Cardiology and, in certain cases, Magnetic resonance imaging.

His research combines Atrophy and Dementia. His work blends Alzheimer's disease and Clinical neurology studies together. His Cognitive decline research incorporates elements of Apolipoprotein E, Cognition, Neuropsychology and Cohort.

Between 2017 and 2021, his most popular works were:

  • NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease (2145 citations)
  • High performance plasma amyloid-β biomarkers for Alzheimer’s disease (497 citations)
  • Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. (153 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Alzheimer's disease

Christopher C. Rowe mostly deals with Alzheimer's disease, Internal medicine, Disease, Dementia and Cognitive decline. His Alzheimer's disease research is multidisciplinary, relying on both Biomarker, Frontotemporal lobar degeneration, Amyloid beta and Neuroscience. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Temporal lobe, Oncology and Cardiology.

His Disease research integrates issues from Positron emission tomography, Prospective cohort study and Neuroimaging. The Dementia study combines topics in areas such as Clinical syndrome, Cohort, Atrophy and Amyloid. His Cognitive decline research includes themes of Audiology, Cognition, Ageing, Apolipoprotein E and Physiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Reisa A. Sperling;Paul S. Aisen;Laurel A. Beckett;David A. Bennett.
Alzheimers & Dementia (2011)

4114 Citations

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo.
Alzheimers & Dementia (2018)

2575 Citations

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)

2389 Citations

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Victor L. Villemagne;Samantha Burnham;Pierrick Bourgeat;Belinda M. Brown.
Lancet Neurology (2013)

1461 Citations

Imaging beta-amyloid burden in aging and dementia.

Christopher C Rowe;Steven Ng;Uwe Ackermann;Sylvia Gong.
Neurology (2007)

1156 Citations

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

Christopher C Rowe;Kathryn A Ellis;Kathryn A Ellis;Miroslava Rimajova;Pierrick Bourgeat.
Neurobiology of Aging (2010)

949 Citations

β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

Kerryn Elizabeth Pike;Gregory Raymond Savage;Victor L Villemagne;Steven Ng.
Brain (2007)

857 Citations

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens.
Alzheimers & Dementia (2016)

845 Citations

Longitudinal Assessment of Aβ and Cognition in Aging and Alzheimer Disease

Victor L Villemagne;Kerryn E Pike;Gaël Chételat;Kathryn A Ellis.
Annals of Neurology (2011)

790 Citations

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

Kathryn A Ellis;Ashley I Bush;David Darby;Daniela De Fazio.
International Psychogeriatrics (2009)

734 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christopher C. Rowe

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 524

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 466

Reisa A. Sperling

Reisa A. Sperling

Brigham and Women's Hospital

Publications: 299

William J. Jagust

William J. Jagust

Helen Wills Neuroscience Institute

Publications: 248

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 241

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 222

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 213

Keith A. Johnson

Keith A. Johnson

Harvard University

Publications: 206

John C. Morris

John C. Morris

Washington University in St. Louis

Publications: 197

Pieter Jelle Visser

Pieter Jelle Visser

Maastricht University

Publications: 192

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 187

Gil D. Rabinovici

Gil D. Rabinovici

University of California, San Francisco

Publications: 173

David S. Knopman

David S. Knopman

Mayo Clinic

Publications: 171

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 161

Ralph N. Martins

Ralph N. Martins

Edith Cowan University

Publications: 161

Oskar Hansson

Oskar Hansson

Lund University

Publications: 159

Trending Scientists

George C. Polyzos

George C. Polyzos

Athens University of Economics and Business

Javier Ramírez

Javier Ramírez

University of Granada

Ignacio Carol

Ignacio Carol

Universitat Politècnica de Catalunya

Zempachi Ogumi

Zempachi Ogumi

Kyoto University

Huige Wei

Huige Wei

Tianjin University of Science and Technology

Wolfgang Peukert

Wolfgang Peukert

University of Erlangen-Nuremberg

P. A. Joy

P. A. Joy

Council of Scientific and Industrial Research

David Bentley

David Bentley

University of Colorado Denver

Gábor L. Lövei

Gábor L. Lövei

Aarhus University

Jean-Marc Ghigo

Jean-Marc Ghigo

Institut Pasteur

Punnee Pitisuttithum

Punnee Pitisuttithum

Mahidol University

Carol E. Franz

Carol E. Franz

University of California, San Diego

Bennett J. Tepper

Bennett J. Tepper

The Ohio State University

Zuo-Feng Zhang

Zuo-Feng Zhang

University of California, Los Angeles

Jennifer D. Davis

Jennifer D. Davis

Brown University

Alfred Vidal-Madjar

Alfred Vidal-Madjar

Institut d'Astrophysique de Paris

Something went wrong. Please try again later.